Ambiq Micro, Inc. (AMBQ) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMBQ SEC filings page.
Ambiq Micro, Inc. (AMBQ) reported $97.9M in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
AMBQ's dominant mechanic is a financed balance-sheet reset alongside persistent operating losses despite wider gross margins.
The FY2025 gross-margin step-up reached44.3% , yet operating margin remained-54.5% ; improved production economics were overwhelmed below gross profit. That gap, alongside SG&A and R&D of$71.6M versus$32.1M gross profit, points to overhead and development spending as the binding operating constraint.
Total liabilities fell from
Operating cash flow improved to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Ambiq Micro, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Ambiq Micro, Inc. has an operating margin of -54.5%, meaning the company loses $55 on every $100 of revenue. This results in a profitability score of 34/100. This is down from -53.4% the prior year.
Ambiq Micro, Inc.'s revenue declined 4.7% year-over-year, from $76.1M to $72.5M. This contraction results in a growth score of 17/100.
Ambiq Micro, Inc. carries a low D/E ratio of 0.14, meaning only $0.14 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 8.76, Ambiq Micro, Inc. holds $8.76 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.
Not available for Ambiq Micro, Inc., and counted as zero in the overall score.
Ambiq Micro, Inc. posts a -22.4% return on equity (ROE), meaning it loses $22 for every $100 of shareholders' equity. This results in a returns score of 27/100.
Ambiq Micro, Inc. scores 37.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.4B) relative to total liabilities ($22.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Ambiq Micro, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Ambiq Micro, Inc. reported a net loss of $36.5M while operations used $19.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Ambiq Micro, Inc. generated $33.9M in revenue in Q2 2026. This represents an increase of 89.7% from the same quarter a year earlier. Against the prior quarter it is up 35.3%.
Ambiq Micro, Inc.'s EBITDA was -$6.9M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 30.2%.
Ambiq Micro, Inc. reported -$7.1M in net income in Q2 2026. This represents an increase of 16.3% from the same quarter a year earlier. Against the prior quarter it is up 30.0%.
Ambiq Micro, Inc. earned -$0.32 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 36.0%.
Cash & Balance Sheet
Ambiq Micro, Inc. held $366.8M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Ambiq Micro, Inc.'s gross margin was 45.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 4.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.
Ambiq Micro, Inc.'s operating margin was -25.7% in Q2 2026, reflecting core business profitability. This is up 23.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.9 percentage points.
Ambiq Micro, Inc.'s net profit margin was -21.0% in Q2 2026, showing the share of revenue converted to profit. This is up 26.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 19.6 percentage points.
Ambiq Micro, Inc.'s ROE was -1.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 2.6 percentage points.
Capital Allocation
Ambiq Micro, Inc. invested $14.1M in research and development in Q2 2026. This represents an increase of 58.9% from the same quarter a year earlier. Against the prior quarter it is up 10.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
AMBQ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1 | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1 | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.9M+89.7% | $25.1M+59.3% | $20.7M | $18.2M-10.4% | $17.9M-11.7% | $15.7M | N/A | $20.3M |
| Cost of Revenue | $18.6M+74.1% | $14.2M+93.0% | $11.9M | $10.5M-23.3% | $10.7M-22.7% | $7.3M | N/A | $13.7M |
| Gross Profit | $15.3M+112.9% | $10.9M+29.8% | $8.9M | $7.7M+16.4% | $7.2M+11.8% | $8.4M | N/A | $6.6M |
| R&D Expenses | $14.1M+58.9% | $12.8M+47.7% | $12.0M | $8.9M-7.1% | $8.9M-5.2% | $8.7M | N/A | $9.6M |
| SG&A Expenses | $9.9M+39.4% | $9.7M+15.5% | $8.8M | $8.8M+24.0% | $7.1M-11.4% | $8.4M | N/A | $7.1M |
| Operating Income | -$8.7M+0.8% | -$11.7M-33.7% | -$12.0M | -$10.0M+0.5% | -$8.8M+19.8% | -$8.7M | N/A | -$10.1M |
| EBITDA | -$6.9M0.0% | -$9.9M-46.7% | -$10.3M | -$8.3M+3.9% | -$6.9M | -$6.8M | N/A | -$8.6M |
| Income Tax | $1K-92.9% | $3K-25.0% | $19K | $3K-76.9% | $14K+100.0% | $4K | N/A | $13K |
| Net Income | -$7.1M+16.3% | -$10.2M-22.8% | -$10.7M | -$9.0M+4.6% | -$8.5M+20.1% | -$8.3M | N/A | -$9.4M |
| EPS (Basic) | -$0.32+98.3% | -$0.50+97.4% | $1.16+104.5% | -$0.72+97.2% | -$18.89+45.4% | -$18.96 | -$25.99 | -$26.03 |
| EPS (Diluted) | -$0.32 | -$0.50 | $1.16 | -$0.72 | -$18.89+45.4% | -$18.96 | -$25.99 | -$26.03 |
| Diluted Shares (Avg) | 22M | 20M | N/A | 12M | 449,785+22.7% | 436,890 | N/A | 374,270 |
Not reported in any period shown, so not listed: Interest Expense.
AMBQ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1 | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1 | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $435.6M+388.6% | $259.5M | $184.7M+77.1% | $186.7M | $89.2M | N/A | $104.3M | N/A |
| Current Assets | $416.6M+456.3% | $241.7M | $167.9M+88.8% | $173.0M | $74.9M | N/A | $89.0M | N/A |
| Cash & Equivalents | $366.8M+672.1% | $204.5M | $140.3M+130.0% | $146.5M | $47.5M | N/A | $61.0M | N/A |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | N/A |
| Inventory | $29.4M+86.3% | $23.5M | $16.9M+12.9% | $16.1M | $15.8M | N/A | $15.0M | N/A |
| Accounts Receivable | $17.5M+125.1% | $11.0M | $7.3M-29.9% | $7.0M | $7.8M | N/A | $10.4M | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | N/A |
| Total Liabilities | $30.9M-92.2% | $24.4M | $22.2M-94.4% | $16.9M | $396.5M | N/A | $396.7M | N/A |
| Current Liabilities | $26.1M+95.5% | $20.6M | $19.2M+63.0% | $13.3M | $13.4M | N/A | $11.8M | N/A |
| Non-Current Liabilities | $4.8M-98.7% | $3.7M | $3.0M-99.2% | $3.7M | $383.1M | N/A | $384.9M | N/A |
| Total Equity | $404.7M+231.7% | $235.2M+178.5% | $162.5M+155.6% | $169.8M+159.8% | -$307.3M-11.1% | -$299.7M | -$292.4M | -$283.8M |
| Retained Earnings | -$374.0M-11.0% | -$366.9M | -$356.7M-11.4% | -$346.0M | -$337.0M | N/A | -$320.3M | N/A |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
AMBQ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1 | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1 | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.5M+20.5% | -$11.2M-894.7% | -$4.1M-1590.2% | -$5.0M+69.7% | -$12.0M | $1.4M | $276K | -$16.6M |
| Depreciation & Amortization | $1.8M-3.7% | $1.7M-11.3% | $1.6M+2.0% | $1.8M+20.0% | $1.9M | $2.0M | $1.6M | $1.5M |
| Stock-Based Compensation | $3.6M+365.0% | $3.4M+295.1% | N/A | $2.1M-2.5% | $765K-53.3% | $851K | N/A | $2.1M |
| Investing Cash Flow | -$1.9M+7.2% | -$4.0M-260.3% | -$2.6M-93.1% | -$1.7M-154.9% | -$2.0M | -$1.1M | -$1.3M | -$670K |
| Financing Cash Flow | $173.6M+642829.6% | $79.4M+53578.4% | $486K-4.9% | $105.7M+1515.8% | $27K | $148K | $511K | $6.5M |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
AMBQ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1 | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1 | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.0%+4.9pp | 43.5%-9.9pp | 42.7% | 42.3%+9.7pp | 40.1%+8.5pp | 53.3% | N/A | 32.6% |
| Operating Margin | -25.7%+23.5pp | -46.6%+8.9pp | -57.7% | -55.3%-5.5pp | -49.2%+4.9pp | -55.6% | N/A | -49.8% |
| Net Margin | -21.0%+26.5pp | -40.6%+12.1pp | -51.5% | -49.6%-3.0pp | -47.5%+5.0pp | -52.7% | N/A | -46.6% |
| Return on Equity | -1.8% | -4.3% | -6.6% | -5.3% | N/A | N/A | N/A | N/A |
| Return on Assets | -1.6%+7.9pp | -3.9% | -5.8% | -4.8% | -9.5% | N/A | N/A | N/A |
| Current Ratio | 15.95+10.3x | 11.70 | 8.76+1.2x | 13.04 | 5.60 | N/A | 7.56 | N/A |
| Debt-to-Equity | 0.08 | 0.10 | 0.14 | 0.10 | N/A | N/A | N/A | N/A |
| Asset Turnover | 0.08-0.1x | 0.10 | 0.11 | 0.10 | 0.20 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ambiq Micro, Inc. AMBQ | FY2025 | $72.5M | -$36.5M | -50.3% | $1.4B | 42/100 |
| ChipMOS TECHNOLOGIES INC IMOS | FY2025 | $762.9M | $17.6M | 2.3% | $1.8B | 41/100 |
| CEVA Inc. CEVA | FY2025 | $109.6M | -$10.6M | -9.7% | $785.8M | 74/100 |
| Alpha and Omega Semiconductor Limited AOSL | FY2026 | $678.9M | -$42.3M | -6.2% | $749.2M | 45/100 |
| SkyWater Technology, Inc. SKYT | FY2025 | $442.1M | $118.9M | 26.9% | $1.6B | 40/100 |
| POET Technologies Inc. POET | FY2025 | $1.1M | -$63.0M | N/A | $1.2B | 18/100 |
Where Ambiq Micro, Inc. Ranks
Frequently Asked Questions
What is Ambiq Micro, Inc.'s annual revenue?
Ambiq Micro, Inc. (AMBQ) reported $72.5M in total revenue for fiscal year 2025. This represents a -4.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ambiq Micro, Inc.'s revenue growing?
Ambiq Micro, Inc. (AMBQ) revenue declined by 4.7% year-over-year, from $76.1M to $72.5M in fiscal year 2025.
Is Ambiq Micro, Inc. profitable?
No, Ambiq Micro, Inc. (AMBQ) reported a net income of -$36.5M in fiscal year 2025, with a net profit margin of -50.3%.
What is Ambiq Micro, Inc.'s EBITDA?
Ambiq Micro, Inc. (AMBQ) had EBITDA of -$32.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Ambiq Micro, Inc.'s gross margin?
Ambiq Micro, Inc. (AMBQ) had a gross margin of 44.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ambiq Micro, Inc.'s operating margin?
Ambiq Micro, Inc. (AMBQ) had an operating margin of -54.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ambiq Micro, Inc.'s net profit margin?
Ambiq Micro, Inc. (AMBQ) had a net profit margin of -50.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ambiq Micro, Inc.'s return on equity (ROE)?
Ambiq Micro, Inc. (AMBQ) has a return on equity of -22.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ambiq Micro, Inc.'s operating cash flow?
Ambiq Micro, Inc. (AMBQ) recorded an outflow of $19.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Ambiq Micro, Inc.'s total assets?
Ambiq Micro, Inc. (AMBQ) had $184.7M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Ambiq Micro, Inc. spend on research and development?
Ambiq Micro, Inc. (AMBQ) invested $38.5M in research and development during fiscal year 2025.
What is Ambiq Micro, Inc.'s current ratio?
Ambiq Micro, Inc. (AMBQ) had a current ratio of 8.76 as of fiscal year 2025, which is generally considered healthy.
What is Ambiq Micro, Inc.'s debt-to-equity ratio?
Ambiq Micro, Inc. (AMBQ) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ambiq Micro, Inc.'s return on assets (ROA)?
Ambiq Micro, Inc. (AMBQ) had a return on assets of -19.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ambiq Micro, Inc.'s P/E ratio?
Ambiq Micro, Inc. (AMBQ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.4B as of Sep 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ambiq Micro, Inc.'s price-to-sales ratio?
Ambiq Micro, Inc. (AMBQ) trades at 14.8x sales, its market capitalization divided by revenue of $97.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Sep 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Ambiq Micro, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Ambiq Micro, Inc. (AMBQ) held $140.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $19.7M over that year. Dividing the one by the other, the reported balance equals about 85 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Ambiq Micro, Inc.'s Altman Z-Score?
Ambiq Micro, Inc. (AMBQ) has an Altman Z-Score of 37.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Ambiq Micro, Inc.'s Piotroski F-Score?
Ambiq Micro, Inc. (AMBQ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ambiq Micro, Inc.'s earnings high quality?
Ambiq Micro, Inc. (AMBQ) reported a net loss of $36.5M while operations used $19.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Ambiq Micro, Inc.?
Ambiq Micro, Inc. (AMBQ) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.